TrialEuropean journal of clinical pharmacology2006

Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone.

Tiina Jaakkola et al.PubMed ↗Publisher ↗

No numbers read from the abstract.